User Tools

Site Tools


dupixent_start

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
dupixent_start [2025/10/28 18:17] 73.123.100.169dupixent_start [2025/11/10 17:04] (current) 73.123.100.169
Line 6: Line 6:
  
 3. Asthma (J45.40 or J45.50) -6 years or older with diagnosis of moderate-to-severe asthma of the following phenotypes:  3. Asthma (J45.40 or J45.50) -6 years or older with diagnosis of moderate-to-severe asthma of the following phenotypes: 
 +
 -eosinophilic (EOs > 150 cells/uL within the past 6 months, or >300 cells/uL within the past year)  -eosinophilic (EOs > 150 cells/uL within the past 6 months, or >300 cells/uL within the past year) 
 +
 -oral corticosteroid dependent asthma requiring documentation of 3 months of patient trying asthma medications including a) high dose ICS, b) additional controller therapy (LABA or leukotriene modifier) and c) oral corticosteroids for at least 6 months (greater than or equal to 5mg per day of prednisone) -oral corticosteroid dependent asthma requiring documentation of 3 months of patient trying asthma medications including a) high dose ICS, b) additional controller therapy (LABA or leukotriene modifier) and c) oral corticosteroids for at least 6 months (greater than or equal to 5mg per day of prednisone)
  
Line 17: Line 19:
 7. COPD (J44) -18 years or older as add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease and a high number of blood eosinophils  7. COPD (J44) -18 years or older as add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease and a high number of blood eosinophils 
  
-PA: Dupixent required through pharmacy benefits insurance; not available to buy & bill through medical benefits at this time (can be costly for Medicare patients because of this)+ 
 +PA: required through pharmacy benefits insurance; not available to buy & bill through medical benefits at this time (can be costly for Medicare patients because of this) 
 + 
 +BCBS FEP insurance will no longer cover Dupixent as of 1/2026. 
 + 
 +link for DWM enrollment forms/ reapplying for PAP: www.dupixentmywayportal.com 
 +(code is 8443879370 aka DMW fax#) 
 + 
 +link to check on copay assistance cards: www.patientrebateonline.com 
 + 
 +direct contact for patient assistance:  
 +Char Williams, Territory Case Manager, Sonexus™ Access and Patient Support  
 +2730 S. Edmonds Lane, Suite 300 | Lewisville, TX  75067 
 +1.844.387.4936 ext. 60656 
 + 
 +Pharmacy for patients to fill med through PAP (no longer Theracom as of 10/1/25):  
 +Sonexus Health Pharmacy Services 
 +2730 S. Edmonds Ln, Ste 400 Lewisville, TX 75067 
 +P: 866-834-0739 
 +F: 469-240-8518 
 +NPI: 1447680210
  
dupixent_start.1761675420.txt.gz · Last modified: 2025/10/28 18:17 by 73.123.100.169

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki